Fulgent Genetics, Inc.

FLGT Healthcare Diagnostics & Research

Fulgent Genetics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $322.7 million, up 13.8% from fiscal 2024. In the quarter to June 2026, revenue grew 4.38%, EPS fell 69.4% and free cash flow grew 25.4%, each against the same quarter a year earlier.

19.81 1.53 −7.17%
Market cap
$587.2M
P/E
0.0×
Fwd P/E
−5.8×
Dividend yield
—
F-score
4/9
Altman Z
5.63
Beneish M
−2.35
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
336.08 258.11 424.15 526.24 450.50 299.37 28.27 31.03 26.48 20.87
Receivables
84.76 69.02 51.13 52.75 138.91 183.86 6.56 5.95 4.01 4.36
Other current assets
22.55 23.02 32.56 48.89 22.55 40.39 2.26 2.56 2.44 0.91
Total current assets
550.49 353.57 507.85 627.87 611.96 523.62 37.08 39.54 32.93 26.14
Property, Plant, Equpment (Net)
112.55 105.55 83.46 81.35 62.29 40.20 5.97 6.45 7.27 6.23
Long-Term Investments
369.27 570.35 423.57 326.65 485.05 132.50 42.82 7.90 16.82 25.60
Goodwill and Intangible Assets (Total)
89.87 92.44 165.11 293.67 86.81 — — — — —
Long Term Assets (Tax, Deferred)
— — — — — — — — 0.13 0.05
Long-term assets (Other)
91.35 98.05 55.34 56.51 32.62 4.14 0.25 0.02 0.04 0.02
Total non-current assets
663.04 866.39 727.48 758.18 666.76 176.85 51.68 14.36 24.26 31.90
Total Assets
1,213.53 1,219.96 1,235.33 1,386.05 1,278.72 700.46 88.76 53.90 57.18 58.04
Notes Payable
0.48 0.41 1.18 5.64 6.15 — — — — —
Accounts Payable
18.65 18.36 15.36 23.09 20.49 26.49 1.58 1.31 2.09 2.76
Accrued Expenses
34.06 24.28 30.74 24.98 17.69 8.45 1.33 1.26 0.91 0.44
Current Part of Debt
— — — 15.00 15.14 15.02 0.00 — — —
Current Part of Taxes to Pay
— — — — 0.79 53.32 0.02 — — 0.12
Other current liabilities
31.78 29.84 25.74 19.40 45.06 26.84 0.37 0.17 1.00 0.44
Total current liabilities
84.97 72.90 73.02 88.11 105.31 130.12 3.72 2.74 3.00 3.32
Long Term Tax Liability (Deferred)
6.94 6.37 7.96 6.00 0.00 (1.00) (0.02) 0.04 0.00 0.24
Non-current Liabilities (Other)
14.91 11.54 21.06 28.07 7.53 0.96 0.00 0.01 0.01 0.00
Total non-current liabilities
21.84 17.91 29.02 28.07 7.53 0.96 2.26 0.01 0.01 0.25
Total liabilities
106.81 90.81 102.04 116.18 112.84 131.07 5.98 2.75 3.01 3.56
Additional Paid In Capital
574.52 543.13 501.72 486.59 501.91 418.07 146.06 114.20 111.88 109.73
Common Stock (Net)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Retained Earnings
529.95 590.47 633.18 801.00 657.60 150.88 (63.43) (63.02) (57.66) (55.15)
Common Equity (Total)
1,106.72 1,129.16 1,133.29 1,269.88 1,165.88 569.39 82.78 51.15 54.18 54.48
Shareholders Equity (Total)
1,106.72 1,129.16 1,133.29 1,269.88 1,165.88 569.39 82.78 51.15 54.18 54.48
Shareholders Equity and Liabilities (Total)
1,213.53 1,219.96 1,235.33 1,386.05 1,278.72 700.46 88.76 53.90 57.18 58.04
Shares (Common)
31.08 30.84 29.65 29.44 30.16 28.18 21.48 18.17 17.85 17.68
Shareholders Equity (Tangible)
1,016.84 1,036.72 968.18 976.21 1,079.07 569.39 82.78 51.15 54.18 54.48
Net Debt
(336.08) (258.11) (424.15) (511.24) (435.36) (284.35) (28.27) (31.03) (26.48) (20.87)
Total Debt
— — — 15.00 15.14 15.02 0.00 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates